Longer Delay for Genentech on New Use of Cancer Drug
606459
Genentech said that approval of its colon cancer drug Avastin as a treatment for breast cancer would be delayed by at least a year.
739572
BARCELONA - A very early test of an experimental drug seemed to slow the spread of advanced deadly skin cancer in a small study, the drug's US developer reported in preliminary findings yesterday.
692230
Genentech Inc. and Swiss drug maker Roche Holding AG said Monday that a recent study showed their colon cancer drug Avastin significantly extended patient survival when combined with oxaliplatin-based chemotherapy drugs.
583059
LONDON, October 6  - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US
208932
GlaxoSmithKline Plc's cervical cancer vaccine Cervarix faces a delay in winning approval in the United States, putting it further behind Merck & Co Inc's rival product Gardasil.
617405
Genentech Inc. said on Thursday it has  updated information on the package insert for its colon cancer  drug Avastin to reflect an increased risk of blood clots that  can cause heart attacks and stroke.
745602
Genentech Inc colon and lung cancer  drug Avastin, along with standard chemotherapy, increases  survival rates of patients with a very deadly type of brain  tumor, U.S. researchers said on Thursday.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
589039
A long, suspicious delay in the study of Merck and Schering's $5 billion drug was reported by Forbes last November.
104063
The FDA has another delay for this HPV vaccine.
498476
Genentech Inc.  on Monday said its  colon cancer drug Avastin extended the life of patients when  used in combination with a chemotherapy regimen called FOLFOX4  more than the chemotherapy alone in a late stage clinical  trial.
140996
A day late and possibly several millions of dollars short. That's the scenario facing one drug manufacturer unless it can get a helping hand from Congress.
13024
U.S. regulators have asked for more data on Novartis AG's  diabetes drug Galvus, possibly delaying approval of the potential blockbuster by a year, which dented its shares while boosting its main rival's.
458999
Merck & Co.  said on Friday it  would delay seeking approval for a combination pill designed to  lower "bad" cholesterol, increase "good" cholesterol and avoid  a common side effect of one of the ingredients.
522221
Altus Pharmaceuticals still testing drug after Genentech leaves development partnership.
409267
Women with early-stage breast cancer may soon get another gene test to help predict whether they are likely to have a recurrence in five to 10 years, information that could influence how aggressively the initial tumor is treated.